Show simple item record

dc.contributor.advisorPadayachee, Neelaveni.
dc.contributor.advisorBangalee, Varsha.
dc.creatorThaver, Tarryn.
dc.date.accessioned2020-12-21T13:09:13Z
dc.date.available2020-12-21T13:09:13Z
dc.date.created2020
dc.date.issued2020
dc.identifier.urihttps://researchspace.ukzn.ac.za/handle/10413/19005
dc.descriptionMasters Degree. University of KwaZulu-Natal, Durban.en_US
dc.description.abstractIntroduction The adoption of medicine pricing regulations was established to counter the on-going global struggle of high medicine prices. South Africa’s healthcare is divided into the private and public sector and each sector functions utilizing different medicine pricing systems i.e. the tender and single exit price (SEP) system. The National Health Insurance (NHI), in its pilot phase in SA, may declare new system changes and improvements. Therefore, increased data on current medicine pricing systems are necessary particularly to assist the NHI process. Aim The overall aim of this study was to compare the medicine prices procured in the public tender system with the private SEP system. Objectives The objectives of the study were to compare pricing trends, determine price differentials, and equate the average price index of a basket of medicines between the public and private healthcare sectors in South Africa. Methods A pricing list consisting of 32 essential medicines available in both the public and private healthcare systems of South Africa was chosen for this study. The price of medicines for the private sector were obtained from the Medicine Price Registry- Open Up website for the period 2014–2018. Public sector medicine prices were obtained from the Department of Health website for the corresponding period. Observations and pricing trends were identified and analysed using Microsoft Excel version 2016. Key Findings A total of 74 medicine brands were analysed in the study. It was found that the prices across both sectors had increased over time, however, the majority of brands (87%) displayed higher prices in the private sector in comparison to the public sector. The price differential between the private and public sector medicines yielded positive values with the median of 252.30%. Conclusion The study found vast price differences between each pricing system due to the different methodologies practiced. Some of the methods and procedures utilized are known, however, both systems lack complete transparency in the processes applied. Therefore, more transparent medicine pricing systems need to be considered for the future of South Africa’s healthcare system as the country transitions toward universal health coverage.en_US
dc.language.isoenen_US
dc.subject.otherMedicine pricing systems - South Africa.en_US
dc.subject.otherMedicines - public tender prices.en_US
dc.subject.otherMedicines - single exit price (SEP).en_US
dc.subject.otherMedicine - cost analysis.en_US
dc.subject.otherMedicine pricing trends - South Africa.en_US
dc.titleA comparison study between public and private healthcare sector medicine prices in South Africa.en_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record